Efficacy and Safety of Oral BT-11 in Ulcerative Colitis
Public ClinicalTrials.gov record NCT03861143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized , Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Ulcerative Colitis
Study identification
- NCT ID
- NCT03861143
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- NImmune Biopharma
- Industry
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Interventions
- BT-11 (440 mg) Drug
- BT-11 (880 mg) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2019
- Primary completion
- Dec 9, 2020
- Completion
- Jun 16, 2021
- Last update posted
- Jun 28, 2023
2019 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Axis Clinical Trials | Los Angeles | California | 90036 | — |
| Ventura Clinical Trials | Ventura | California | 93003 | — |
| Clinical Research of California | Walnut Creek | California | 94598 | — |
| Medycal Research Inc. | Brooksville | Florida | 34613 | — |
| Invesclinic.U.S,LLC.FL | Fort Lauderdale | Florida | 33308 | — |
| I.H.S Health LLC | Kissimmee | Florida | 34741 | — |
| Smart Medical Research | Richmond Hill | New York | 11102 | — |
| Invesclinic.U.S,LLC. | McAllen | Texas | 78503 | — |
| Texas Gastroenterology Associates | Spring | Texas | 77386 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03861143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03861143 live on ClinicalTrials.gov.